Shire PLC. - Company & Market Research Reports

Shire is a global biotechnology company that focuses on rare diseases and other highly specialized conditions. The company's products are available in more than 100 countries across core therapeutic areas including hematology, immunology, neuroscience, lysosomal storage disorders, oncology and ophthalmics. It has offices in Dublin, Chicago and Zug, Switzerland. Shire was founded in 1986 by Harry Stratford, Dennis Stephens, Peter Moriarty, and Geoff Hall.


Immunoglobulin A Nephropathy Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, Patient Size, and Epidemiology Forecast to 2025 - Product Thumbnail Image

Immunoglobulin A Nephropathy Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, Patient Size, and Epidemiology Forecast to 2025

  • Report
  • 130 Pages
From
Ocular Hypertension: Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Ocular Hypertension: Drug Development Pipeline Study, H1 2018

  • Report
  • 61 Pages
From
Hemochromatosis/Iron Overload Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Hemochromatosis/Iron Overload Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 67 Pages
From
Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 85 Pages
From
Hereditary Angioedema (HAE) Therapeutics - Pipeline Analysis 2017, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Hereditary Angioedema (HAE) Therapeutics - Pipeline Analysis 2017, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 105 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Report
  • 482 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Investigation Report on China's Celecoxib Market, 2010-2019 - Product Thumbnail Image

Investigation Report on China's Celecoxib Market, 2010-2019

  • Report
  • 20 Pages
From
Viral Conjunctivitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Viral Conjunctivitis - Pipeline Review, H1 2018

  • Report
  • 34 Pages
From
Global Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
2018 Short Bowel Syndrome Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Short Bowel Syndrome Drug Development- Pipeline Analysis Report

  • Report
  • 45 Pages
From
2018 Eosinophilic Esophagitis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Eosinophilic Esophagitis Drug Development- Pipeline Analysis Report

  • Report
  • 45 Pages
From
2018 Colitis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Colitis Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • 611 Pages
From
Secondary Hyperparathyroidism - Pipeline Review, H2 2018 - Product Thumbnail Image

Secondary Hyperparathyroidism - Pipeline Review, H2 2018

  • Report
  • 38 Pages
From
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015 - Product Thumbnail Image

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015

  • Report
  • 57 Pages
From
Viral Conjunctivitis - Pipeline Insight, 2018 - Product Thumbnail Image

Viral Conjunctivitis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Ophthalmic Drugs Market by Indication, Type, Dosage Form, Technology, Distribution Channel, and Therapeutic Class - Global Opportunity Analysis and Industry Forecast, 2017-2023 - Product Thumbnail Image

Ophthalmic Drugs Market by Indication, Type, Dosage Form, Technology, Distribution Channel, and Therapeutic Class - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Report
  • 351 Pages
From
Secondary Hyperparathyroidism - Pipeline Insight, 2018 - Product Thumbnail Image

Secondary Hyperparathyroidism - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Hyperparathyroidism - Pipeline Insight, 2018 - Product Thumbnail Image

Hyperparathyroidism - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Loading Indicator
adroll